01076nas a2200277 4500000000100000008004100001260001700042653001200059653003000071653001100101653002200112653001100134653001200145653000900157653001300166100001400179700001700193700001500210700001900225245007000244300001000314490000700324050003200331520042100363022001400784 1987 d c1987 Jan-Mar10aDapsone10aDrug Therapy, Combination10aFemale10aFollow-Up Studies10aHumans10aleprosy10aMale10aRifampin1 aRamanan R1 aManglani P R1 aGhorpade A1 aBhagoliwal S K00aFollow-up study of pauci-bacillary leprosy on-multi-drug regimen. a50-530 v59 aInfolep Library - available3 a
One hundred and twenty nine newly registered cases of pauci-bacillary leprosy were put on Dapsone daily and Rifampicin once a month and were followed up for one year. Out of 129 cases, 108 (83.7%) were found to be clinically active at the end of one year of multidrug treatment (MDT). In 25 out of these 108 cases, skin biopsy was done and well defined granulomas were seen after therapy in 11 patients (44%).
a0254-9395